GUESTS: Zavain Dar - Partner @ Lux Capital & Nan Li - Managing Director @ Obvious Ventures

Zavain Dar is a Partner @Lux Capital & invests at the intersection and union of cutting-edge biotech and software. Zavain has led Lux’s investments in Primer, a machine intelligence startup; Clarifai, which democratizes cutting edge deep neural networks; Auransa, which is developing novel medicines based on computational insight applied to genomic data; Recursion (NASDAQ: RXRX) which uses automation and deep learning to develop drugs for rare diseases; Tempo Automation, which applies software and automation to electronics manufacturing; Rigetti Computing, which is fabricating some of the fastest quantum chips in the world; Braid, which is bringing AI to medical diagnostics; Visor, which aims to simplify tax preparation; Computable Labs, which is building a decentralized data marketplace; Cryptonumerics, a data control company acquired by Snowflake Computing; The Stacks Foundation, which is making Bitcoin programmable; Runway, which is putting machine learning tools into the hands of creators; LabGenius, a protein drug discovery company; Anagenex, a drug discovery company leveraging DNA encoded libraries; Hugging Face, an open-source company democratizing Natural Language Processing; Dyno Therapeutics, an AI-powered gene therapy company; Enveda Biosciences, which is translating nature into medicine; Gandeeva, cryo-electron microscopy drug discovery; A-Alpha Bio, a protein-protein interaction synthetic biology platform; Nomic, a proteomics company; and Thrive Earlier Detection, an early cancer detection company that Exact Sciences agreed to acquire for $2.15 billion in 2020.

&

Nan Li is a Managing Director @ Obvious Ventures, where he leads Obvious’ investments in computational biology visionaries like Zymergen, Recursion Pharmaceuticals, and LabGenius; AI-driven platforms opening new opportunities across sectors such as Planet, Inato, and DarwinAI; and intelligent robotics companies like Dexterity.
_______________________

Join BIOS Community 🎉
Become a member, continue the conversation, connect with like-minded Life Science innovators, access exclusive resources, & invite-only events…

Apply to Join —https://docs.google.com/forms/d/e/1FAIpQLSft6P6HhSwMDJbFEW9j7HU6vZwjza9PRNN5ZdSGENj7HwhL7A/viewform

For More Interesting Content 💭

🦾 Website: https://www.bios.community/
🧬 Podcast: https://open.spotify.com/show/2HmcPq9k8fYpn60F3hw6Ra?si=uH9wk7SiRAiVUeP1dmwi7Q
🧪 Medium: https://medium.com/bios-community
🩺 Twitter: https://twitter.com/bios_community
🦠 LinkedIn: https://www.linkedin.com/company/bios-community
🧠 Substack: https://bioscommunity.substack.com

_______________________

BIOS: Nucleus of Life Science Innovation 🚀

Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Create Radical Advances in Human Health🌟

(From Youtube)